These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9392626)

  • 21. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.
    Kita E; Yunou Y; Kurioka T; Harada H; Yoshikawa S; Mikasa K; Higashi N
    Infect Immun; 2000 Mar; 68(3):1207-14. PubMed ID: 10678928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.
    Sheng L; Rasco B; Zhu MJ
    Appl Environ Microbiol; 2016 Nov; 82(22):6531-6540. PubMed ID: 27590808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome.
    Chaisri U; Nagata M; Kurazono H; Horie H; Tongtawe P; Hayashi H; Watanabe T; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Microb Pathog; 2001 Aug; 31(2):59-67. PubMed ID: 11453701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
    Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
    Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7.
    de Sablet T; Chassard C; Bernalier-Donadille A; Vareille M; Gobert AP; Martin C
    Infect Immun; 2009 Feb; 77(2):783-90. PubMed ID: 19064636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
    Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
    Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of iron transport gene on pathogenicity-associated island of uropathogenic Escherichia coli in E. coli O157:H7 containing Shiga toxin gene.
    Ye C; Xu J
    J Clin Microbiol; 2001 Jun; 39(6):2300-5. PubMed ID: 11376076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.
    Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH
    Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colistin inhibits E. coli O157:H7 Shiga-like toxin release, binds endotoxins and protects Vero cells.
    Percivalle E; Monzillo V; Pauletto A; Marone P; Imberti R
    New Microbiol; 2016 Apr; 39(2):119-23. PubMed ID: 27196550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.
    Petruzziello-Pellegrini TN; Yuen DA; Page AV; Patel S; Soltyk AM; Matouk CC; Wong DK; Turgeon PJ; Fish JE; Ho JJ; Steer BM; Khajoee V; Tigdi J; Lee WL; Motto DG; Advani A; Gilbert RE; Karumanchi SA; Robinson LA; Tarr PI; Liles WC; Brunton JL; Marsden PA
    J Clin Invest; 2012 Feb; 122(2):759-76. PubMed ID: 22232208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7.
    Kim SH; Yang SJ; Koo HC; Bae WK; Kim JY; Park JH; Baek YJ; Park YH
    J Food Prot; 2001 Nov; 64(11):1667-73. PubMed ID: 11726142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of pathogenic Escherichia coli isolated from humans in Austria: phenotypes, toxin gene types and epidemiology.
    Wagner M; Allerberger F; Manafi M; Lindner G; Friedrich AW; Sonntag AK; Foissy H
    J Vet Med B Infect Dis Vet Public Health; 2004 Aug; 51(6):288-92. PubMed ID: 15458492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, quantification and isolation of pathogenic shiga toxin Escherichia coli O157:H7 along the production and supply chain of pork around Hubei Province of China.
    Khan SB; Zou G; Xiao R; Cheng Y; Rehman ZU; Ali S; Memon AM; Fahad S; Ahmad I; Zhou R
    Microb Pathog; 2018 Feb; 115():93-99. PubMed ID: 29273508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins.
    Neri P; Nagano SI; Yokoyama S; Dohi H; Kobayashi K; Miura T; Inazu T; Sugiyama T; Nishida Y; Mori H
    Microbiol Immunol; 2007; 51(6):581-92. PubMed ID: 17579269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification & characterization of Shiga toxin-producing Escherichia coli isolates from patients with diarrhoea in Iran.
    Bonyadian M; Momtaz H; Rahimi E; Habibian R; Yazdani A; Zamani M
    Indian J Med Res; 2010 Sep; 132():328-31. PubMed ID: 20847380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isogenic strain of Escherichia coli O157:H7 that has lost both Shiga toxin 1 and 2 genes.
    Feng P; Dey M; Abe A; Takeda T
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):711-7. PubMed ID: 11427416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the transcription of the Escherichia coli O157:H7 genes coding for shiga-like toxins and intimin, and its potential use in the treatment of human infection with the bacterium.
    Matar GM; Rahal E
    Ann Trop Med Parasitol; 2003 Apr; 97(3):281-7. PubMed ID: 12803859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans.
    Besser TE; Shaikh N; Holt NJ; Tarr PI; Konkel ME; Malik-Kale P; Walsh CW; Whittam TS; Bono JL
    Appl Environ Microbiol; 2007 Feb; 73(3):671-9. PubMed ID: 17142358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.